NCT05683171 A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT05681403 Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma Status NOT_YET_RECRUITING Phase NA
NCT05676450 Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas Status RECRUITING Phase NA
NCT05673785 A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05663502 Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers Status RECRUITING Phase N/A
NCT05655546 ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals Status TERMINATED Phase NA
NCT05654675 Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET Status RECRUITING Phase N/A
NCT05646576 Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy Status RECRUITING Phase NA
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05631886 Combination of CAR-DC Vaccine and ICIs in Malignant Tumors Status RECRUITING Phase PHASE1
NCT05618041 The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies Status RECRUITING Phase NA
NCT05600959 Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH Status NOT_YET_RECRUITING Phase N/A
NCT05598268 A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. Status UNKNOWN Phase PHASE1/PHASE2
NCT05567887 A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT05565898 PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma Status NOT_YET_RECRUITING Phase N/A
NCT05544968 Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies Status RECRUITING Phase PHASE1
NCT05540340 A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE1